HIV/AIDS
Brand/Generic Name
Dosage/Strength
Status
Restrictions
Notes
Relative Cost
Agenerase
amprenavir
15 mg/mL Solution
Not Applicable
Agenerase
amprenavir
50 mg capsule
Not Applicable
Aptivus
tipranavir
250 mg capsule
Not Applicable
ATRIPLA
efavirenz-emtricitabin-tenofov
600-200-300 mg tablet
Not Applicable
Combivir
lamivudine-zidovudine
150-300 mg tablet
Not Applicable
Complera
emtricitab-rilpivirine-tenofov
200-25-300 mg tablet
$$$$
Crixivan
indinavir
100 mg capsule; 333 mg capsule; 200 mg capsule; 400 mg capsule
Not Applicable
Edurant
rilpivirine
25 mg tablet
Not Applicable
Emtriva
emtricitabine
10 mg/mL Solution
Not Applicable
Emtriva
emtricitabine
200 mg capsule
Not Applicable
Epivir
lamivudine
10 mg/mL Solution
Not Applicable
Epivir
lamivudine
300 mg tablet; 150 mg tablet
Not Applicable
Epzicom
abacavir-lamivudine
600-300 mg tablet
Not Applicable
Fuzeon
enfuvirtide
90 mg Kit
$$$$$+
Fuzeon
enfuvirtide
90 mg Recon Soln
$$$$$+
Intelence
etravirine
25 mg tablet; 200 mg tablet; 100 mg tablet
Not Applicable
Invirase
saquinavir mesylate
200 mg capsule
Not Applicable
Invirase
saquinavir mesylate
500 mg tablet
Not Applicable
Isentress
raltegravir
400 mg tablet
Not Applicable
Kaletra
lopinavir-ritonavir
100-25 mg tablet; 200-50 mg tablet
Not Applicable
Kaletra
lopinavir-ritonavir
133.3-33.3 mg capsule
Not Applicable
Kaletra
lopinavir-ritonavir
400-100 mg/5 mL Solution
Not Applicable
Lexiva
fosamprenavir
50 mg/mL Suspension
Not Applicable
Lexiva
fosamprenavir
700 mg tablet
Not Applicable
Norvir
ritonavir
100 mg capsule
Not Applicable
Norvir
ritonavir
100 mg tablet
Not Applicable
Norvir
ritonavir
80 mg/mL Solution
Not Applicable
Prezista
darunavir
100 mg/ml suspension
Not Applicable
Prezista
darunavir
150 mg tablet
Not Applicable
Prezista
darunavir
75 mg tablet; 400 mg tablet; 600 mg tablet; 300 mg tablet
Not Applicable
Prezista
darunavir
800 mg tablet
Not Applicable
Retrovir
zidovudine
10 mg/mL Solution
Not Applicable
Retrovir
zidovudine
10 mg/mL Syrup
Not Applicable
Retrovir
zidovudine
100 mg capsule
Not Applicable
Retrovir
zidovudine
300 mg tablet
Not Applicable
Reyataz
atazanavir
300 mg capsule; 100 mg capsule; 150 mg capsule; 200 mg capsule
Not Applicable
Selzentry
maraviroc
150 mg tablet; 300 mg tablet
Not Applicable
Stribild
elvitegr-cobicist-emtric-tenof
150-150-200-300 mg tablet
Not Applicable
Sustiva
efavirenz
200 mg capsule; 50 mg capsule; 100 mg capsule
Not Applicable
Sustiva
efavirenz
600 mg tablet
Not Applicable
Trizivir
abacavir-lamivudine-zidovudine
300-150-300 mg tablet
Not Applicable
Truvada
emtricitabine-tenofovir
200-300 mg tablet
Not Applicable
Videx 2 gram Pediatric
didanosine
10 mg/mL (Final) Recon Soln
Not Applicable
Videx EC
didanosine
250 mg capsule,delayed release(DR/EC); 125 mg capsule,delayed release(DR/EC); 200 mg capsule,delayed release(DR/EC); 400 mg capsule,delayed release(DR/EC)
Not Applicable
Viracept
nelfinavir
250 mg tablet; 625 mg tablet
Not Applicable
Viramune
nevirapine
200 mg tablet
Not Applicable
Viramune
nevirapine
50 mg/5 mL Suspension
Not Applicable
Viramune XR
nevirapine
400 mg tablet extended release 24 hr
Not Applicable
Viread
tenofovir disoproxil fumarate
150 mg tablet; 200 mg tablet; 250 mg tablet; 300 mg tablet
Not Applicable
Viread
tenofovir disoproxil fumarate
40 mg/scoop (40 mg/gram) Powder
Not Applicable
Zerit
stavudine
1 mg/mL Recon Soln
Not Applicable
Zerit
stavudine
15 mg capsule; 30 mg capsule; 20 mg capsule; 40 mg capsule
Not Applicable
Ziagen
abacavir
20 mg/mL Solution
Not Applicable
Ziagen
abacavir
300 mg tablet
Not Applicable
Key for Product(s) Listed Above
Formulary
Prior Authorization (PA may not be required for some benefit plans)
Non-Formulary
(Third tier coverage applies for selected plans)
Not Reimbursed
Quantity Limit
Not available through mail order as 90-day supply*
Step Therapy
Generic Available. Brand name medication may be covered at a higher member cost or may not be covered for certain plans.
Notes
$
Relative cost compared to others in category
Specialty distribution for selected plans (Fourth or fifth tier coverage applied for selected plans)
© 2002 Managed Markets Insight and Technology, LLC. All Rights Reserved